{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Scalp+Psoriasis&page=2", "query": { "condition": "Scalp Psoriasis", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Scalp+Psoriasis&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-05-22T04:01:25.700Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01368887", "title": "Study to Test the Effectiveness of a New Treatment for Scalp Psoriasis", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "DPS-102", "type": "DRUG" }, { "name": "Vehicle / Placebo", "type": "OTHER" }, { "name": "Calcipotriol Monotherapy", "type": "DRUG" }, { "name": "Nicotinamide Monotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "DermiPsor, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2013-04", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2011-06-08", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Brockton, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Brockton", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01368887" }, { "nct_id": "NCT05969223", "title": "Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Genital Psoriasis", "Scalp Psoriasis" ], "interventions": [ { "name": "Risankizumab", "type": "DRUG" }, { "name": "Placebo for Risankizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 214, "start_date": "2023-08-10", "completion_date": "2025-11-28", "has_results": true, "last_update_posted_date": "2026-02-24", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 38, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Encino, California + 32 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05969223" }, { "nct_id": "NCT01083758", "title": "Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scalp Psoriasis" ], "interventions": [ { "name": "LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 31, "start_date": "2010-04", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2025-03-11", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 6, "location_summary": "San Diego, California • Jacksonville, Florida • Ormond Beach, Florida + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Ormond Beach", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01083758" }, { "nct_id": "NCT03897088", "title": "Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Scalp Psoriasis" ], "interventions": [ { "name": "PART 1: Double-blind Placebo-controlled", "type": "DRUG" }, { "name": "PART 2: Double-blind Active Treatment Extension", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 231, "start_date": "2019-03-29", "completion_date": "2022-02-17", "has_results": true, "last_update_posted_date": "2023-05-31", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 19, "location_summary": "Encinitas, California • Fountain Valley, California • Fremont, California + 15 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fremont", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03897088" }, { "nct_id": "NCT06095102", "title": "A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "JNJ-77242113", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 311, "start_date": "2023-10-12", "completion_date": "2027-02-17", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 28, "location_summary": "Scottsdale, Arizona • Fort Smith, Arkansas • Encinitas, California + 24 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Alpharetta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06095102" }, { "nct_id": "NCT01690299", "title": "Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" }, { "name": "Placebo injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2012-10-01", "completion_date": "2016-04-04", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Bakersfield, California • Irvine, California + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01690299" }, { "nct_id": "NCT01139580", "title": "The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Calcipotriene Foam", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stiefel, a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 363, "start_date": "2010-05", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 26, "location_summary": "Tucson, Arizona • San Diego, California • Denver, Colorado + 22 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01139580" }, { "nct_id": "NCT05028582", "title": "Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Scalp Psoriasis" ], "interventions": [ { "name": "Roflumilast Foam 0.3%", "type": "DRUG" }, { "name": "Vehicle Foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcutis Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 432, "start_date": "2021-08-24", "completion_date": "2022-06-03", "has_results": true, "last_update_posted_date": "2025-07-17", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 36, "location_summary": "Scottsdale, Arizona • Beverly Hills, California • Encinitas, California + 31 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05028582" }, { "nct_id": "NCT04128007", "title": "Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "Roflumilast foam 0.3%", "type": "DRUG" }, { "name": "Vehicle foam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcutis Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 304, "start_date": "2020-01-13", "completion_date": "2020-09-25", "has_results": true, "last_update_posted_date": "2022-10-26", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 31, "location_summary": "Rogers, Arkansas • Fremont, California • San Diego, California + 27 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "Fremont", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" }, { "city": "Boynton Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04128007" }, { "nct_id": "NCT07340216", "title": "Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "ARQ-154 Foam 0.3%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcutis Biotherapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 16, "start_date": "2025-12-15", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-05-22T04:01:25.700Z", "location_count": 5, "location_summary": "Bryant, Arkansas • Miami Lakes, Florida • Meridian, Idaho + 2 more", "locations": [ { "city": "Bryant", "state": "Arkansas" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "West Lafayette", "state": "Indiana" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07340216" } ] }